Expanding the Utility of SBRT in Hepatobiliary and Pancreas Malignancies
Stereotactic Body Radiation Therapy (SBRT), a modern approach for delivering ablative radiation doses, has dramatically increased the utility of radiotherapy in hepatobiliary and pancreas malignancies. This presentation will review the current indications for SBRT in managing primary and metastatic liver and pancreas malignancies and examine the potential of expanding its utility.
Stereotactic Radiotherapy Treatment of Hepatobiliary and Pancreatic Tumours
An update on the latest treatment techniques and technologies available for SBRT in hepatobiliary and pancreatic malignancies. This will also include an overview of MR Linac based treatment and Proton Beam Therapy as well as more conventional treatment platforms.
Single-shot Celiac Plexus Radiosurgery: New Palliative Modality for Pancreatic Cancer
Pancreatic cancer is characterized by severe epigastric pain radiating to the lower back in a belt-like distribution. The pain is caused by infiltration of the celiac plexus, a network of nociceptive nerves adherent to the anterior aspect of the abdominal aorta. Contemporary approaches (opioids, chemical neurolysis, systemic chemotherapy) are often inadequate. We hypothesized that ablative […]
SRT for Cancers of Digestive System
The effectiveness of radiation therapy for esophageal cancer is still insufficient. Why? The role of radiation therapy for gastric cancer is often in doubt. Radiation therapy for rectal cancer is effective, but there are nuances. Are we doing everything right? We will try to find the answers to these and other questions about radiotherapy of […]
SBRT for Liver Lesions
Stereotactic body radiation therapy (SBRT) represents a promising option in the management of liver lesions, both metastases and primary tumors. Through the ability to deliver high ablative doses to the tumor and low doses to the healthy liver and other organs at risk, SBRT has been reported to reach high rates of local control and […]
SBRT for Borderline Resectable/Locally Advanced Pancreatic Cancer
Pancreatic ductal adenocarcinoma is characterized by a poor prognosis, with a 5-year overall survival rate of about 6%. Surgery is the gold standard of care with 5-year OS rates of 20% to 25%. More than 50% of patients, however, are borderline resectable or unresectable at the time of diagnosis, mainly due to locally advanced disease […]
SBRT for Liver
This talk was focused on 1) The rational of for liver SBRT; 2) The clinical indications for liver SBRT; 3) The management strategies (fractionation and post treatment assessment) for SBRT; 4) SBRT workflow; 5) Delivery techniques and 6) The motion management techniques.